Literature DB >> 33249183

Nutritional modulation of leptin expression and leptin action in obesity and obesity-associated complications.

Sergio Montserrat-de la Paz1, Antonio Pérez-Pérez1, Teresa Vilariño-García1, Carlos Jiménez-Cortegana1, Francisco Javier G Muriana2, María C Millán-Linares2, Victor Sánchez-Margalet3.   

Abstract

In obesity, an elevated accumulation and dysregulation of adipose tissue, due to an imbalance between energy intake and energy expenditure, usually coexists with the loss of responsiveness to leptin in central nervous system, and subsequently with hyperleptinemia. Leptin, a peptide hormone mainly produced by white adipose tissue, regulates energy homeostasis by stimulating energy expenditure and inhibiting food intake. Human obesity is characterized by increased plasma leptin levels, which have been related with different obesity-associated complications, such as chronic inflammatory state (risk factor for diabetes, cardiovascular and autoimmune diseases), as well as infertility and different types of cancer. Besides, leptin is also produced by placenta, and high leptin levels during pregnancy may be related with some pathological conditions such as gestational diabetes. This review focuses on the current insights and emerging concepts on potentially valuable nutrients and food components that may modulate leptin metabolism. Notably, several dietary food components, such as phenols, peptides, and vitamins, are able to decrease inflammation and improve leptin sensitivity by up- or down-regulation of leptin signaling molecules. On the other hand, some food components, such as saturated fatty acids may worsen chronic inflammation increasing the risk for pathological complications. Future research into nutritional mechanisms that restore leptin metabolism and signals of energy homeostasis may inspire new treatment options for obesity-related disorders.
Copyright © 2020. Published by Elsevier Inc.

Entities:  

Keywords:  Adipose tissue; Leptin; Leptin resistance; Obesity; Postprandial metabolism

Year:  2020        PMID: 33249183     DOI: 10.1016/j.jnutbio.2020.108561

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  6 in total

1.  Leptin Protein Expression and Promoter Methylation in Ovarian Cancer: A Strong Prognostic Value with Theranostic Promises.

Authors:  Mourad Assidi; Fatimah M Yahya; Maryam H Al-Zahrani; Razan Elkhatib; Ali Zari; Aisha Elaimi; Jaudah Al-Maghrabi; Ashraf Dallol; Abdelbaset Buhmeida; Muhammad Abu-Elmagd
Journal:  Int J Mol Sci       Date:  2021-11-28       Impact factor: 5.923

2.  Hyperleptinemia results in systemic inflammation and the exacerbation of ischemia-reperfusion myocardial injury.

Authors:  Ekaterina A Polyakova; Evgeny N Mikhaylov; Michael M Galagudza; Evgeny V Shlyakhto
Journal:  Heliyon       Date:  2021-11-26

3.  Red-Skin Extracts of Lotus Seeds Alleviate High-Fat-Diet Induced Obesity via Regulating Lipoprotein Lipase Activity.

Authors:  Hong Xu; Hang Gao; Feiyue Liu; Lingxiao Gong
Journal:  Foods       Date:  2022-07-13

Review 4.  Chrono-communication and cardiometabolic health: The intrinsic relationship and therapeutic nutritional promises.

Authors:  Pamela Senesi; Anna Ferrulli; Livio Luzi; Ileana Terruzzi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-13       Impact factor: 6.055

Review 5.  T Cell Protein Tyrosine Phosphatase in Glucose Metabolism.

Authors:  Ya-Nan Wang; Shiyue Liu; Tingting Jia; Yao Feng; Xin Xu; Dongjiao Zhang
Journal:  Front Cell Dev Biol       Date:  2021-06-29

Review 6.  Role of Leptin in Non-Alcoholic Fatty Liver Disease.

Authors:  Carlos Jiménez-Cortegana; Alba García-Galey; Malika Tami; Pilar Del Pino; Isabel Carmona; Soledad López; Gonzalo Alba; Víctor Sánchez-Margalet
Journal:  Biomedicines       Date:  2021-06-30
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.